Member Info for Aldebaran

Wyn your right TW can't influence price himself however if you read my post I am suggesting he and his band of merry men when operating together can have some influence. Add that to GSA who could be involved and if the SB firms haven't bought stock to cover all the long positions in combination with the DB article and suddenly you have a coordinated attack deliberate in it's goal to bring down the SP. I just suggest this is possible.

I also agree with you about avactas missed timelines and the previous CEO.

Would you agree with me that Since CC took over things seem much improved? And that there has been nothing but good news and good communications since she did.

Avacta is in a far better position now cc is at the helm and yet investors if you can call them that haven't changed. It's like they're scared of there own shadow and think a placing is due every day so the slightest bit if fud and they're capitulating

I've already told you that a number of large holders forced AS out due to the placing debacle. That's a fact. I can't prove it on here of course so take it or leave it but I know that's what happened. He had no back up plan and that was his mistake.

Spreadbet firms still not allowing longs to take positions, have they not been covering the longs they have taken perhaps?

GSA still need to close there short

Tom winnifilth and his army of sycophants with there multiple aliases out in force trying to spread FUD

Hilarious article spreading FUD by the husband of an ex Avacta employee who was fired recently released.

Is all the above linked? Because it seems to me avacta are on the verge I'd greatness and the start of an almighty coshare price correction or they're lying to us and it is Ribena after all. It either works or it doesn't. It's that simple if your investment horizon is longer than the next 5 minutes

Spreadbet firms still closed for longs.

This is unusual question but does anyone think that the spreadbet firms have taken peoples bets without actually buying the shares in the market to cover them?

That as well as GSA's short and that analysts own axe to grind along with serial shorter winnifilth there's a lot of vested interests here perhaps to see the stock drop. Catch a load of stops and buy up PI's shares before the next wave up??

Something very fishing is going on here especially in light of that update which was exceptional if you have done more than 15minutes of actual research on this stock

And STILL the spreadbet firms remain SHUT for long positions.

Manipulation of the highest order here.

.

STILL

Chris has already said there's more news to come soon.

She's not messing around this one and I personally wouldn't want to be on the wrong side of an RNS from Avacta. Now of all times especially

P1b was added in by avacta so taking it out is not exactly skipping a necessary phase is it.

I believe it would give more certainty around p2 and fast track approval but I don't think it is absolutely necessary. Given the data we have on 6k I say it's better than dox and so avacta should just go for it.

Skip p1b and pick an indication for p2. It's high time this got into patients in my view and I'm sure it's being discussed at board level

I think Chris is hard to predict and steadfast in her determination to expedite this to patients.

I also think the data so far is solid. Solid enough to "take a chance" on just 1 indication for p2. Sgs or sts and I think precision does its thing and I think dox does its thing.

I would not rule out Chris surprising the market with this strategy change no

With such solid data now is there any real need for a phase 1b. Could avacta be debating on moving straight to p2 with SGS or a couple of subsets of STS ?

That would really put the cat among the pidgens

Yeah all focus on the pipeline.

Not sure what the newly formed SAB is even for. Oh, wait... you're talking shh it again

Chris said there's more to come.

They are sat on more data since the cut of on 19th (2 additional scans fron q2w)

We have investor meet coming up

And I'm sure pipeline reveal isn't to far away.

Ok some are disappointed the share price hasn't done 300% in first 30mins lmao!

I don't care who is right or wrong I care about a6k coming to market which looks inevitable now.

It doesn't need to be more efficacious than standard dox, it just needs to be safer... which it is.

Ava6k alone multiples anyones investment at this level by 10x or more

Throw in the pipeline and affimer platform and this becomes that once in a lifetime stock that makes people millionaires from relatively small investments

It's safer than dox Thorn

So all it needs to do is be at least as efficacious and as Dr Tap so eloquently put it, this becomes standard of care. OVERNIGHT.

as we know 100x more dox is in tumour than blood and we know half life is not an issue then why would cleaved dox by any less efficacious than straight dox?

All logic says it will be more efficacious in anthracycline naive 1st line patients with high fap dox sensitive tumours. But it doesn't need to be more efficacious does it.

Ava6000 now surely has more than a 10% chance of coming to market LOL !

Then as the MOA & POC are proven plus we've learnt our drugs are targeting and breaking down the stroma, and 2nd and 3rd gen drugs can be highly modulated it looks like our pipeline is going to attract a lot of attention.

Do you not agree with the above? If not then maybe you should move on, go invest in Novartis and take your 2% dividend each year or whatever it is

So we are saying what?

During this safety study most (how many) patients have seen progression free survival?

This I think is just the high fap patients but still remarkable given prior treatments. I almost don't believe what I'm seeing. Is that what we're saying, that 20+ patients saw progression free survival?

Stock now trading above the 200dma with golden cross imminent and price has doubled off its lows with no financial changes that wear aware of so price has not fallen after every bit of good news at all. If it wasn't for the leaked placing price would still be ranging in my view and nobody would be complaining

Who might stop a bid at 150p?

lol

How about the majority of PI's who wouldn't accept

The board of directors who wouldn't recommend it and finally

Other big pharmaceutical companies who wont sit by while one of their rivals snaps up the technology to revolutionise the treatment of solid tumours without putting forward there own (improved) bid for the company.

A bidding war is inevitable. if that was a jenuine quiestion then dont worry about a low ball offer

Look at the attendees there will be all sorts there including big pharma and investors of big funds on the look out for next big thing and plenty of scientists etc...

Just because we know all about avacta, what Christina had for lunch and Simons every bowl movement etc... it doesn't mean everyone knows about avacta and are choosing not to invest in it. We're in early and just have to wait patiently. You either believe in the science and that deals/TO's will come you don't need it validating by others when you've done enough research

Also CC states in this video clinical proof of concept and mechanism proven. Ive heard her and other scientists say this multiple times.

How much more obvious to people want this to be made? It works folks. It works and there is absolutely no way BP are now all over this, even if its just to judge the threat avacta poses over its investment in ADC's